Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Eton Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +5 vs. Q4 2022
- Shares held
- 5.84M
- −88.1K (−1.5%) vs. Q4 2022
- Total value
- $22.5M
- +$4.36M (+24.1%) vs. Q4 2022
- New holders
- 10
- 7 more added
- Sold out
- 5
- 7 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,185,000 | $8.41M | 2.52% | +15,000+0.7% | Added |
| Vanguard Group Inc | 980,283 | $3.77M | 0.00% | +55,180+6.0% | Added |
| Westside Investment Management, Inc. | 517,301 | $1.99M | 0.58% | −36,900−6.7% | Reduced |
| Acuitas Investments, LLC | 468,687 | $1.80M | 1.86% | +468,687 | New |
| Paradigm Capital Management Inc | 300,000 | $1.16M | 0.08% | 00.0% | Unchanged |
| BlackRock Inc. | 292,665 | $1.13M | 0.00% | +1,914+0.7% | Added |
| Bridgeway Capital Management, LLC | 241,462 | $929.6K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 186,582 | $718.3K | 0.00% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 158,676 | $610.9K | 0.08% | −304,644−65.8% | Reduced |
| Stratos Wealth Partners, LTD. | 92,310 | $355.4K | 0.01% | +92,310 | New |
| Bank of New York Mellon Corp | 79,402 | $305.7K | 0.00% | +530+0.7% | Added |
| State Street Corp | 71,003 | $273.4K | 0.00% | 00.0% | Unchanged |
| Lido Advisors, LLC | 44,000 | $169.4K | 0.00% | +44,000 | New |
| Blair William & Co | 35,000 | $134.8K | 0.00% | −3,157−8.3% | Reduced |
| Northern Trust Corp | 33,090 | $127.4K | 0.00% | +2,735+9.0% | Added |
| Virtu Financial LLC | 17,380 | $67.0K | 0.01% | −171−1.0% | Reduced |
| Chicago Trust Co NA | 16,700 | $64.3K | 0.02% | 00.0% | Unchanged |
| Prudential Financial Inc | 16,200 | $62.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 15,889 | $61.2K | 0.00% | +694+4.6% | Added |
| Renaissance Technologies LLC | 13,400 | $52.0K | 0.00% | +13,400 | New |
| Charles Schwab Investment Management Inc | 13,239 | $51.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 11,909 | $45.9K | 0.00% | +11,909 | New |
| Quantum Private Wealth, LLC | 11,500 | $44.3K | 0.02% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,964 | $42.2K | 0.00% | +10,964 | New |
| Raymond James & Associates | 10,000 | $38.5K | 0.00% | +10,000 | New |
| UBS Group AG | 5,387 | $20.7K | 0.00% | +1,448+36.8% | Added |
| Tower Research Capital LLC (TRC) | 3,401 | $13.0K | 0.00% | −246−6.7% | Reduced |
| Morgan Stanley | 2,704 | $10.4K | 0.00% | −5,437−66.8% | Reduced |
| Truvestments Capital LLC | 1,848 | $7.12K | 0.00% | +1,848 | New |
| Plante Moran Financial Advisors, LLC | 1,000 | $3.85K | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 1,000 | $3.85K | 0.00% | +1,000 | New |
| BNP Paribas Arbitrage, SA | 350 | $1.35K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 370 | $1.00K | 0.00% | +370 | New |
| Wells Fargo & Company | 145 | $558 | 0.00% | −3,998−96.5% | Reduced |
| Lindbrook Capital, LLC | 4 | $15 | 0.00% | 00.0% | Unchanged |
| Roumell Asset Management, LLC | 0 | $0 | 0.00% | −449,438−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,835−100.0% | Sold out |
| Kraematon Investment Advisors, Inc | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Financial Advisors Network, Inc. | – | – | – | – | Not filed |